INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial... von Panés, Julian, Bouma, Gerd, Ferrante, Marc, Kucharzik, Torsten, Nachury, Maria, de la Portilla de Juan, Fernando, Reinisch, Walter, Selvaggi, Francesco, Tschmelitsch, Jörg, Brett, Neil R, Ladouceur, Martin, Binek, Matthias, Hantsbarger, Gary, Campbell-Hill, Sarah, Karki, Chitra, Buskens, Christianne

Volltext

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration von Rosenfeld, Philip J., Heier, Jeffrey S., Hantsbarger, Gary, Shams, Naveed

Volltext

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-co... von KEREIAKES, D. J, KLEIMAN, N. S, HANTSBARGER, G. L, BRYZINSKI, B, TOPOL, E. J, FERGUSON, J. J, ZAKI MASUD, A. R, BRODERICK, T. M, ABBOTTSMITH, C. W, RUNYON, J. P, ANDERSON, L. C, ANDERS, R. J, DREILING, R. J

Volltext

P340 Real-world treatment patterns and recurrence rates of rectovaginal fistulas in patients with Crohn’s disease: A retrospective cohort database analysis von Karki, C, Latremouille-Viau, D, Gilaberte, I, Hantsbarger, G, Romdhani, H, Lightner, A

Volltext

DOP57 Predictive modelling to examine long term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn’s Disease von Maruszczak, M, Genenz, K, Turkstra, E, Fenu, E, Hantsbarger, G, Gilaberte, I, Karki, C, Panes, J

Volltext

EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study von Karki, C, Geransar, P, Hantsbarger, G, Lee, K, Perovic, M, Raven, L, Sajak-Szczerba, M, Sharpe, E, Silber, A, Tozer, P

Volltext

Ranibizumab for treatment of neovascular age-related macular degeneration : A phase I/II multicenter, controlled, multidose study von HEIER, Jeffrey S, ANTOSZYK, Andrew N, SHAMS, Naveed, PAVAN, Peter Reed, LEFF, Steven R, ROSENFELD, Philip J, CIULLA, Thomas A, DREYER, Richard F, GENTILE, Ronakl C, SY, Judy P, HANTSBARGER, Gary

Volltext

DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists von Cohen, R, Bhayat, F, Hantsbarger, G, Blake, A, Vermeire, S

Volltext

P585 Examining faecal incontinence and its impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a multi-country burden of illness study... von Karki, C, Athavale, A, Hantsbarger, G, Lee, K, Milicevic, S, Perovic, M, Raven, L, Sajak-Szczerba, M, Sharpe, E, Tozer, P

Volltext

P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex p... von Zmora, O, Baumgart, D C, Faubion, W, Ferrante, M, Gecse, K, Genestin, E, Geransar, P, Hantsbarger, G, Karki, C, Tozer, P, Panés, J

Volltext

P516 Discrete choice experiment to examine patient preferences for surgical interventions in patients with Crohn’s perianal fistulas: results from a global burden of illness study... von Karki, C, Athavale, A, Hantsbarger, G, Lee, K, Milicevic, S, Perovic, M, Raven, L, Sajak-Szczerba, M, Abilash, V, Tozer, P

Volltext

P315 High symptom burden and impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a global burden of illness study von Karki, C, Sharpe, E, Hantsbarger, G, Lee, K, Perovic, M, Raven, L, Sajak-Szczerba, M, Silber, A, Yoon, A, Tozer, P

Volltext

P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data von Card, T, Ungaro, R, Bhayat, F, Blake, A, Hantsbarger, G, Travis, S

Volltext

P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry von Louis, E, Muls, V, Bossuyt, P, Colard, A, Nakad, A, Baert, D, Mana, F, Caenepeel, P, Vanden Branden, S, Vermeire, S, D’Heygere, F, Strubbe, B, Cremer, A, Setakhr, V, Baert, F, Vijverman, A, Coenegrachts, J L, Flamme, F, Hantson, A, Bennett, D, Van Gassen, G, Hantsbarger, G

Volltext

P600 Vedolizumab dose optimisation: Findings from a Belgian registry von Louis, E, Muls, V, Bossuyt, P, Colard, A, Nakad, A, Baert, D, Mana, F, Caenepeel, P, Vanden Branden, S, Vermeire, S, D’Heygere, F, Strubbe, B, Cremer, A, Coche, J C, Setakhr, V, Baert, F, Vijverman, A, Coenegrachts, J L, Flamme, F, Hantson, A, Wijnen, K, Piters, E, Hantsbarger, G, Dolin, P

Volltext

P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry von Louis, E, Muls, V, Bossuyt, P, Colard, A, Nakad, A, Baert, D, Mana, F, Caenepeel, P, Vanden Branden, S, Vermeire, S, D’Heygere, F, Strubbe, B, Cremer, A, Coche, J-C, Setakhr, V, Baert, F, Vijverman, A, Coenegrachts, J L, Flamme, F, Hantson, A, Wijnen, K, Piters, E, Hantsbarger, G, Wan, F, Jiang, B, Dolin, P

Volltext

686 Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects von Martin, N, Lewis, R.A, Vogel, R, Sheth, N, Sargent, B, Swearingen, D, Rasmussen, S, Hantsbarger, G, Novack, G.D

Volltext

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment von KEREIAKES, D. J, KLEIMAN, N, FERGUSON, J. J, RUNYON, J. P, BRODERICK, T. M, HIGBY, N. A, MARTIN, L. H, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J

Volltext

Milacemide: Safety assessment in senile dementia of the Alzheimer type von Dysken, Maurice W., Fakouhi, T. Daniel, Skare, Stacy S., Mendels, Joseph, LeWitt, Peter, Hendrie, Hugh C., Venable, Thomas C., Hantsbarger, Gary L., Herting, Robert L.

Volltext

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary intervention von KEREIAKES, D. J, RUNYON, J. P, KLEIMAN, N. S, HIGBY, N. A, ANDERSON, L. C, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J

Volltext